Effects of botulinum toxin A on functional outcome during distraction osteogenesis

Journal of Orthopaedic Research

Volumn 25, Issue 5, 2007, Pages 656-664

  Olabisi, Ronke ^a   Best, Thomas M ^b   Vanderby Jr , Ray ^a   Petr, Sarah ^a   Noonan, Kenneth J ^a  

^a University of Wisconsin Madison   (United States)

^b OHIO UNIVERSITY   (United States)

Author keywords

Botulinum toxin; Callotasis; Callus distraction; Distraction osteogenesis; Limb lengthening; Type A

Indexed keywords

BOTULINUM TOXIN A; SODIUM CHLORIDE;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISTRACTION OSTEOGENESIS; DRUG EFFICACY; DRUG MECHANISM; EXPERIMENTAL RABBIT; FOLLOW UP; GASTROCNEMIUS MUSCLE; LEG LENGTHENING; MUSCLE CONTRACTURE; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; PES EQUINUS; PRIORITY JOURNAL; RANGE OF MOTION; TIBIA; TIBIALIS ANTERIOR MUSCLE; TREATMENT OUTCOME;

ACHILLES TENDON; ANIMALS; BONY CALLUS; BOTULINUM TOXIN TYPE A; MODELS, ANIMAL; MUSCLE CONTRACTION; MUSCLE, SKELETAL; NEUROMUSCULAR AGENTS; ORGAN SIZE; OSTEOGENESIS, DISTRACTION; POSTOPERATIVE COMPLICATIONS; RABBITS; RANGE OF MOTION, ARTICULAR; RECOVERY OF FUNCTION; TIBIA; TORQUE;

EID: 34248388971     PISSN: 07360266     EISSN: None     Source Type: Journal    
DOI: 10.1002/jor.20349     Document Type: Article

References (34)

1. Day CS, Moreland MS, Floyd SS Jr, et al. 1997. Limb lengthening promotes muscle growth. J Orthop Res 15: 227-234.
2. Fitch RD, Thompson JG, Rizk WS, et al. 1996. The effects of the Ilizarov distraction technique on bone and muscle in a canine model: a preliminary report. Iowa Orthop J 16: 10-19.
3. Holm I, Steen H, Ludvigsen P, et al. 1995. Unchanged muscle function after bilateral femoral lengthening. A prospective study of 9 patients with a 2-year follow-up. Acta Orthop Scand 66:258-260.
4. Kanbe K, Hasegawa A, Takagishi K, et al. 1998. Analysis of muscle bioenergetic metabolism in rabbit leg lengthening. Clin Orthop Relat Res 351:214-221.
5. Maffulli N, Fixsen JA. 1995. Muscular strength after callotasis limb lengthening. J Pediatr Orthop 15:212-216.
6. Matano T, Tamai K, Kurokawa T. 1994. Adaptation of skeletal muscle in limb lengthening: a light diffraction study on the sarcomere length in situ. J Orthop Res 12: 193-196.
7. Polo A, Aldegheri R, Zambito A, et al. 1997. Lower-limb lengthening in short stature. An electrophysiological and clinical assessment of peripheral nerve function. J Bone Joint Surg [Br] 79:1014-1018.
8. Williams P, Simpson H, Kyberd P, et al. 1999. Effect of rate of distraction on loss of range of joint movement, muscle stiffness, and intramuscular connective tissue content during surgical limb-lengthening: a study in the rabbit. Anat Rec 255:78-83.
9. De Deyne PG, Meyer R, Paley D, et al. 2000. The adaptation of perimuscular connective tissue during distraction osteogenesis. Clin Orthop Relat Res 379:259-269.
10. Makarov MR, Kochutina LN, Samchukov ML, et al. 2001. Effect of rhythm and level of distraction on muscle structure: an animal study. Clin Orthop Relat Res 384: 250-264.
11. Simpson AH, Williams PE, Kyberd P, et al. 1995. The response of muscle to leg lengthening. J Bone Joint Surg [Br] 77-B:630-636.
12. Sproul JT, Price CT. 1992. Recent advances in limb lengthening. Part II: biological advances. Orthop Rev 21: 425-430.
13. De Deyne PG, Kinsey S, Yoshino S, et al. 2002. The adaptation of soleus and edl in a rat model of distraction osteogenesis: IGF-1 and fibrosis. J Orthop Res 20:1225-1231.
14. Fink B, Neuen-Jacob E, Lienert A, et al. 2001. Changes in canine skeletal muscles during experimental tibial lengthening. Clin Orthop Relat Res 385:207-218.
15. Shilt JS, Deeney VF, Quinn CO. 2000. The effect of increased distraction frequency on soft tissues during limb lengthening in an animal model. J Pediatr Orthop 20: 146-150.
16. Williams P, Simpson H, Kenwright J, et al. 2001. Muscle fibre damage and regeneration resulting from surgical limb distraction. Cells Tissues Organs 169:395-400.
17. Yamazaki H, Abe M, Kanbara K. 2003. Changes of fiber type ratio and diameter in rabbit skeletal muscle during limb lengthening. J Orthop Sci 8:75-78.
18. De Deyne PG, Hayatsu K, Meyer R, et al. 1999. Muscle regeneration and fiber-type transformation during distraction osteogenesis. J Orthop Res 17:560-570.
19. Lindsey CA, Makarov MR, Shoemaker S, et al. 2002. The effect of the amount of limb lengthening on skeletal muscle. Clin Orthop Relat Res 402:278-287.
20. Caiozzo VJ, Utkan A, Chou R, et al. 2002. Effects of distraction on muscle length: mechanisms involved in sarcomerogenesis. Clin Orthop Relat Res 4035:S133-S145.
21. Fink B, von Giesen HJ, Wilcke C, et al. 2000. Electromyographically evident changes in skeletal muscles during tibial lengthening in dogs using the Ilizarov method. Arch Orthop Trauma Surg 120:79-83.
22. Kaljumae U, Martson A, Haviko T, et al. 1995. The effect of lengthening of the femur on the extensors of the knee. An electromyographic study. J Bone Joint Surg [Am] 77-A: 247-250.
23. Nogueira MP, Paley D, Bhave A, et al. 2003. Nerve lesions associated with limb-lengthening. J Bone Joint Surg [Am] 85-A:1502-1510.
24. Green SA, Horton E, Baker M, et al. 2002. Distraction of skeletal muscle: evolution of a rat model. Clin Orthop Relat Res 4035:S126-S132.
25. Paley D. 1990. Problems, obstacles, and complications of limb lengthening by the Ilizarov technique. Clin Orthop Relat Res 250:81-104.
26. Stanitski DF. 1994. The effect of limb lengthening on articular cartilage. An experimental study. Clin Orthop Relat Res 301:68-72.
27. Segev E, Hayek S. 2003. Adjustable bracing technique for the prevention of knee flexion contracture during tibial lengthening. J Pediatr Orthop 23:385-386.
28. Rossetto O, Caccin P, Rigoni M, et al. 2002. The metalloprotease activity of tetanus and botulinum neurotoxins. In: Brin MF, Hallett M, Jankovic J, editors. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Williams; p 3-9.
29. Fock J, Galea MP, Stillman BC, et al. 2004. Functional outcome following botulinum toxin A injection to reduce spastic equinus in adults with traumatic brain injury. Brain Injury 18:57-63.
30. Johnson CA, Wood DE, Swain ID, et al. 2002. A pilot study to investigate the combined use of botulinum neurotoxin type A and functional electrical stimulation, with physiotherapy, in the treatment of spastic dropped foot in subacute stroke. Artif Organs 26:263-266.
31. Parratte B, Tatu L, Vuillier F, et al. 2002. Intramuscular distribution of nerves in the human triceps surae muscle: anatomical bases for treatment of spastic drop foot with botulinum toxin. Surg Radiol Anat 24:91-96.
32. Pittock SJ, Moore AP, Hardiman O, et al. 2003. A double-blind randomised placebo-controlled evaluation of three doses of botulinum toxin type A (Dysport) in the treatment of spastic equinovarus deformity after stroke. Cerebrovasc Dis 15:289-300.
33. Brin MF, Hallett M, Jankovic J, editors. 2002. Scientific and therapeutic aspects of botulinum toxin. Philadelphia: Lippincott Williams & Williams.
34. Best TM, McCabe RP, Corr D, et al. 1998. Evaluation of a new method to create a standardized muscle stretch injury. Med Sci Sports Exerc 30:200-205.